Indeed, a higher expression level of the NK cell marker NCR1 was correlated with a better event-free survival and overall survival of neuroblastoma patient cohorts83 (Fig. 7i; Supplementary Fig. 7a), regardless of risk and MYCN status (Supplementary Fig. S7b–e). Here, NCR1 is linked to neuroblastoma.